Driven by a growing geriatric population, rising gastrointestinal (GI) disease burden, and a major shift toward outpatient minimally invasive procedures, the United States endoscopy devices market is undergoing significant expansion. Advanced visualization technologies, single-use scope innovations, and AI-assisted diagnostics are reshaping surgical suites and ambulatory centers across the country.
According to industry data, the United States endoscopy devices market is projected to expand from US$ 12.17 billion in 2025 to US$ 22.04 billion by 2034, advancing at a Compound Annual Growth Rate (CAGR) of 6.82% between 2026 and 2034.
United States Endoscopy Devices Market Overview
Endoscopy devices consist of specialized, illuminated optical tubes (flexible or rigid) paired with high-definition cameras, video processors, and mechanical instruments. Inserted through natural orifices or tiny keyhole incisions, these systems allow clinicians to visualize internal organ structures, obtain biopsies, excise tissue, and treat internal conditions without traditional open surgery.
U.S. ENDOSCOPY DEVICES MARKET VALUATION (2025–2034)
$25.0 B ───────────────────────────────────────────── $22.04 B
/
$20.0 B ────────────────────────────────────────────/
/
$15.0 B ────── $12.17 B ─────────────────────────/
(2025) (2034)
• Compound Annual Growth Rate (CAGR): 6.82% (2026–2034)
• Primary End-User Segment: Hospitals & Ambulatory Surgical Centers (ASCs)
• Leading Tech Drivers: High-Definition/4K Imaging, AI Integration, Single-Use Scopes
In the U.S., diagnostic and therapeutic endoscopy volumes are high, supported by established preventive screening guidelines (such as screening colonoscopies for colorectal cancer). Modern gastroenterology, pulmonology, urology, and laparoscopic specialties rely heavily on endoscopic equipment to reduce patient recovery times, lower hospital infection rates, and lower overall healthcare costs.
Core Market Growth Drivers
1. Rising Incidence of GI Diseases and Cancer Burden
The clinical necessity for precise diagnostic tools is driven by the growing burden of gastrointestinal and respiratory conditions in the U.S.
- Economic & Procedural Volume: Gastrointestinal health expenditures exceed $111 billion annually in the U.S., driving tens of millions of emergency visits, hospital admissions, and endoscopies every year.
- Oncology Screenings: With over 2 million new cancer cases projected annually in the U.S. (including substantial GI, lung, and urological malignancies), early detection programs rely directly on high-resolution endoscopes for lesion detection and biopsies.
- Research Funding: Federal support remains strong, with the National Institutes of Health (NIH) allocating over $3.6 billion annually to GI research, boosting clinical interest in advanced diagnostic techniques.
2. Rapid Migration to Outpatient & Ambulatory Surgical Centers (ASCs)
Patients and healthcare networks are choosing outpatient settings over overnight inpatient stays.
- Outpatient Preference: Minimally invasive endoscopic interventions minimize tissue trauma, reduce post-operative pain, and enable same-day discharge.
- Ophthalmology & Specialized Advances: Innovations are expanding into niche surgical specialties. For instance, BVI launched its FDA-approved Leos™ Laser Endoscopy Ophthalmic System, with its first clinical procedure performed by Dr. Nathan Radcliffe at the Ambulatory Surgery Center of Greater New York in the Bronx.
3. High-Definition Visualization, Robotics, and AI Integration
Technological innovation is replacing older standard-definition systems with 4K visualization towers, cloud-archiving software, and artificial intelligence.
- AI-Assisted Diagnostic Systems: FDA clearance of AI systems—such as AnX Robotica’s NaviCam capsule endoscopy system—is enabling real-time detection of small-bowel lesions and adenomas, improving diagnostic accuracy.
- Enhanced Optical Depth: Manufacturers continue pushing depth-of-field and lighting capabilities. In May 2025, Olympus secured FDA 510(k) clearance for its EZ1500 endoscopes featuring Extended Depth of Field (EDOF) technology.
Market Challenges and Operational Obstacles
Capital Outlays and Out-of-Pocket Patient Costs
Advanced endoscopic video towers, high-definition camera heads, and robotic-assisted attachments represent substantial capital investments for hospitals and ASCs. Equipment maintenance contracts and rapid software obsolescence add ongoing operational expense. For patients, high deductibles or out-of-pocket costs for specialized non-routine procedures can create financial hurdles, despite insurance coverage.
Cross-Contamination Risks and Reprocessing Directives
Reprocessing complex, reusable flexible endoscopes requires multi-step cleaning, high-level disinfection, and strict sterilization protocols. Inadequate sterilization carries cross-contamination risks and healthcare-associated infections (HAIs). Consequently, regulatory oversight has intensified, accelerating adoption of single-use, disposable endoscopes to guarantee patient safety.
Analysis by Product & Clinical Application
Mechanical Endoscopic Equipment & Accessories
Mechanical accessories—such as biopsy forceps, snares, retrieval baskets, scissors, and dilators—are high-volume consumable components. As the frequency of therapeutic tissue removal, polyp excision, and foreign body retrieval grows, mechanical accessories provide steady, recurring revenue for device manufacturers.
Bronchoscopy & Respiratory Devices
Driven by smoking history, industrial exposure, and rising incidence of chronic obstructive pulmonary disease (COPD) and lung cancer, bronchoscopy equipment adoption is increasing. Navigational bronchoscopy and flexible high-definition video bronchoscopes allow pulmonologists to reach peripheral lung lesions for precise early-stage sampling.
Laparoscopy Devices
Laparoscopic systems remain central to general, gynecological, and urological surgeries. High-definition laparoscopes paired with robotic platforms enable surgeons to perform complex abdominal procedures, such as bariatric, hernia repair, and gallbladder surgeries, with improved dexterity and visualization.
Key End-User Settings & Regional U.S. Dynamics
Hospitals vs. Ambulatory Surgical Centers (ASCs)
Hospitals maintain the largest market share due to their ability to fund expensive surgical suites, manage acute emergency interventions, and process high procedural volumes. However, standalone ASCs represent the fastest-growing end-user segment, driven by lower overhead costs, shorter turnaround times, and favorable reimbursement structures for outpatient care.
State-Level Market Dynamics
┌────────────────────────────────────────────────────────────────────────┐
│ KEY U.S. REGIONAL MARKET HIGHLIGHTS │
├──────────────┬─────────────────────────────────────────────────────────┤
│ California │ High population density, leading research centers, and │
│ │ early adoption of robotic-assisted endoscopy platforms. │
├──────────────┼─────────────────────────────────────────────────────────┤
│ New York │ Strong academic medical presence; strategic alliances │
│ │ (e.g., Scivita Medical partnering with Boston │
│ │ Scientific for single-use scope distribution). │
├──────────────┼─────────────────────────────────────────────────────────┤
│ New Jersey │ Commercial density of major pharmaceutical & medtech │
│ │ firms; cloud-endoscopy pilots (e.g., NTT & Olympus). │
├──────────────┼─────────────────────────────────────────────────────────┤
│ Washington │ Innovation-focused network with expanding ASC hubs and │
│ │ rapid integration of newly cleared FDA devices. │
└──────────────┴─────────────────────────────────────────────────────────┘
Market Segmentation Summary
By Product Type
- Endoscopes (Flexible, Rigid, Capsule)
- Endoscopy Visualization & Documentation Systems
- Mechanical Endoscopic Equipment
- Accessories & Consumables
- Other Specialized Systems
By Application
- Gastrointestinal (GI) Endoscopy
- Laparoscopy
- Bronchoscopy / Pulmonology
- Urology Endoscopy
- Arthroscopy & Neuroendoscopy
- Gynecology & ENT Endoscopy
By Hygiene & Device Format
- Single-Use / Disposable Endoscopes
- Reusable Endoscopes (Reprocessing & Sterilization)
By End-User
- Hospitals
- Ambulatory Surgery Centers (ASCs)
- Specialty Clinics & Outpatient Settings
Key U.S. States Covered
California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, Kentucky, and the Rest of the United States.
Leading Market Players Analyzed
Johnson & Johnson (Ethicon), Stryker Corporation, Boston Scientific Corporation, CONMED Corporation, Medtronic plc, FUJIFILM Holdings, and Smith & Nephew plc.
Frequently Asked Questions (FAQs)
1. What is the projected market size for endoscopy devices in the U.S. by 2034?
The U.S. endoscopy devices market is projected to reach US$ 22.04 billion by 2034, up from US$ 12.17 billion in 2025.
2. What is the expected CAGR for the U.S. endoscopy market?
The market is forecasted to grow at a Compound Annual Growth Rate (CAGR) of 6.82% from 2026 to 2034.
3. Why are single-use (disposable) endoscopes gaining market share?
Single-use scopes eliminate cross-contamination risks, reduce healthcare-associated infections (HAIs), and avoid the operational labor and expenses associated with manual scope reprocessing and sterilization.
4. How is artificial intelligence (AI) being used in endoscopy?
AI software integrates with visualization towers to assist clinicians in real-time, highlighting hidden adenomas, mucosal abnormalities, and early-stage cancerous lesions during procedures.
5. What role do Ambulatory Surgical Centers (ASCs) play in this market?
ASCs are driving volume growth by offering lower-cost, same-day outpatient endoscopic procedures that provide fast recovery times and reduced hospital stay expenses for patients.
6. Which clinical applications account for the highest endoscopy device usage?
Gastrointestinal (GI) procedures—such as colonoscopies and upper endoscopies—account for the largest operational volume, followed by laparoscopy, urology, and pulmonology (bronchoscopy).
7. What are the main obstacles facing device manufacturers?
Key challenges include the high upfront cost of capital equipment, complex regulatory approval processes, and strict infection control compliance for reusable scopes.
